Results 81 to 90 of about 145,320 (184)

Can We Manage Without Biopsy in Membranous Nephropathy With Positive anti-PLA2R Antibodies?

open access: yesNefrología (English Edition), 2019
Introduction. Our study compares 2 immunosuppressive strategies to reduce tacrolimus nephrotoxicity and its risk of acute tubular necrosis: delayed introduction of tacrolimus plus thymoglobulin vs initial tacrolimus plus basiliximab on the results of kidney transplant (KT) using type-III donation after circulatory death (III-DCD).
Ruiz-Martínez, L.   +9 more
openaire   +3 more sources

Anti-phospholipase A2 Receptor Antibody Measurement in Patients with Idiopathic Membranous Nephropathy Diagnosed by Renal Biopsy [PDF]

open access: yes, 2023
Objective: Our study is a cross-sectional study that aims to evaluate the presence and levels of anti-phospholipase A2 receptor (PLA2R) antibodies in healthy volunteers and idiopathic membranous nephropathy (IMN) patients and to assess the relationship ...
Usalan, Celalettin   +3 more
core   +1 more source

Bilateral drusenoid deposits with subretinal fluid and cystoid macular edema in a serum anti-phospholipase A2 receptor antibody positive patient: A case report

open access: yesHeliyon
Introduction: Phospholipase A2 receptor (PLA2R) is a major target antigen in idiopathic membranous nephropathy (IMN). IMN was often reported to have retinal vascular abnormalities secondary to hypercoagculability or hypertension.
Hailiang Wu   +4 more
doaj   +1 more source

Antigenic modulation limits the efficacy of anti-CD20 antibodies: implications for antibody selection

open access: yes, 2010
Rituximab, a monoclonal antibody which targets CD20 on B-cells, is now central to the treatment of a variety of malignant and autoimmune disorders. Despite this success a substantial proportion of B-cell lymphomas are unresponsive or develop resistance ...
French, R.R.   +31 more
core   +1 more source

Nephrotic Syndrome: Beyond Common Causes

open access: yesNephrology, Volume 30, Issue 4, April 2025.
ABSTRACT We report the case of a 38‐year‐old Caucasian man with well‐controlled HIV on antiretroviral therapy who developed nephrotic syndrome. The patient presented with a maculopapular rash, lymphadenopathy, oral lesions, nasal congestion and bilateral pitting oedema. Laboratory tests revealed hypoalbuminemia, nephrotic range proteinuria and abnormal
Humam Hazim   +4 more
wiley   +1 more source

Behaviour of non-donor specific antibodies during rapid re-synthesis of donor specific HLA antibodies after antibody incompatible renal transplantation [PDF]

open access: yes, 2013
Background: HLA directed antibodies play an important role in acute and chronic allograft rejection. During viral infection of a patient with HLA antibodies, the HLA antibody levels may rise even though there is no new immunization with antigen ...
Rizwan Hamer   +35 more
core   +1 more source

Serum phospholipase A2 receptor antibody is associated with thrombogenesis in patients with idiopathic membranous nephropathy

open access: yesKidney & Blood Pressure Research
Introduction: Patients with idiopathic membranous nephropathy (IMN) are particularly susceptible to thromboembolism (TE). The phospholipase A2 receptor (PLA2R) antibody (Ab) has been indicated to work as an independent risk predictor for venous TE in IMN.
Qinling Zhang, Guiling Liu
doaj   +1 more source

Hepatitis B Antigenaemia, Nephrotic Syndrome and Pulmonary Embolism A Series of Unfortunate Events: A Case Report

open access: yesRespirology Case Reports, Volume 13, Issue 3, March 2025.
We present an interesting case where a patient with chronic hepatitis B infection develops antigenaemia and nephrotic syndrome, and subsequent pulmonary embolism, highlighting the intricate interplay between viral hepatitis, renal disease and hypercoagulability. ABSTRACT Hepatitis B is a major health concern.
Muhammad Hassaan Malik   +4 more
wiley   +1 more source

Interpretation and Clinical Value of Serum Anti-PLA2R-Antibody Testing

open access: yesThe Journal of Applied Laboratory Medicine, 2021
Prapa, Pattrapornpisut   +2 more
openaire   +2 more sources

Case Report: Successful Treatment of Dermatomyositis With Telitacicept

open access: yesCase Reports in Medicine, Volume 2025, Issue 1, 2025.
Dermatomyositis is an autoimmune disease. Common treatment with glucocorticoids, immunoglobulins, methotrexate, and rituximab is recommended. Telitacicept is an immunosuppressant that has been approved for the treatment of systemic lupus erythematosus in recent years.
Xinyu Fu   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy